questionText: To ask the Secretary of State for Health and Social Care, whether national guidance has been issued to Integrated Care Boards on the prescribing of fezolinetant following its approval for NHS use.
answerText: The National Institute for Health and Care Excellence (NICE) published guidance on 31 March 2026 recommending fezolinetant as an option for treating moderate to severe menopause-related hot flushes and night sweats when hormone replacement therapy is unsu...
heading: Fezolinetant